Alzamend Neuro, Inc. Common Stock
ALZNAlzamend Neuro, Inc. (ALZN) is a biopharmaceutical company focused on developing innovative treatments for neurodegenerative and psychiatric disorders. The company's pipeline primarily includes therapies targeting conditions such as Alzheimer's disease, with an emphasis on novel approaches to address unmet medical needs in mental health and neurological health.
Company News
Over 25 therapies from 20+ pharmaceutical companies are currently in various clinical trial stages for bipolar disorder treatment, with promising new drug candidates targeting different neurological mechanisms.
The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider t...
The Dow Jones index closed lower by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider ...
$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying The Dow Jones index closed lower by over 150 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a fac...
Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the consensus of $1.28 billion. EPS of $0.49 surpassed the consensus of $0.48. For FY23, AEO revised guidance for revenue to be up mid-single digits...
